Brain Cancer News and Features

Bone marrow produces glioma treatment

Genetic material secreted by bone marrow cells was used to reduce glioma tumor volume in a recent study.

Personalized brain mapping technique preserves function after brain tumor surgery

The imaging technique of DTI allows neurosurgeons to visualize important pathways in the brain. This allows them to better adapt brain tumor surgeries and preserve language, visual function, and motor function while removing cancerous tissue.

Low T3 syndrome predicts unfavorable outcomes in surgical patients with brain tumor

Among patients undergoing surgery for a brain tumor, low T3 (triiodothyronine) syndrome has been found to be predictive of unfavorable clinical outcomes and depressive symptoms.

Poor thyroid function foretells worse outcome after brain-tumor surgery

Low levels of the thyroid hormone triiodothyronine (T3) predict unfavorable outcomes after neurosurgery for the treatment of brain tumors.

Stem cells from fat may aid glioblastoma treatment

Adipose tissue may provide a more efficient, less costly, and less invasive source of mesenchymal stem cells (MSCs) than bone marrow.

Dasatinib thwarts brain cancer metastasis after bevacizumab use

Combining the antiangiogenic bevacizumab with the kinase inhibitor dasatinib stopped glioblastoma metastasis after shrinking the tumors.

5-ALA fluorescence guide improves resection of glioblastoma multiforme

Fluorescence form 5-aminolevulinic acid (5-ALA) has been used to guide resection of recurrent GBM. Before surgery, the patient ingests 5-ALA, then the tumor cells fluoresce intraoperatively in response to certain wavelengths of light.

Genomic sequencing identifies mutant 'drivers' of meningioma brain tumors

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15% of brain tumors known as meningiomas.

Using a growth forecast to predict brain tumor response to treatment

The forecast enables physicians to rapidly identify how well a tumor is responding to a particular therapy and allows a quick pivot to a new therapy in a critical time window if the current therapy is not effective.

ELTD1 protein may be new biomarker for glioma

ELTD1, a protein linked with angiogenesis, is the strongest candidate for a significant association with glioma out of nearly 200 possible markers.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs